- Home
- EVMN vs ASPN Comparison
EVMN vs ASPN Comparison
Compare EVMN & ASPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVMN | ASPN |
|---|---|---|
| Founded | 2020 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | RETAIL: Building Materials |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 474.7M | 407.5M |
| IPO Year | 2025 | 2011 |
Fundamental Metrics
Financial Performance| Metric | EVMN | ASPN |
|---|---|---|
| Price | $9.60 | $5.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $43.88 | $4.25 |
| AVG Volume (30 Days) | 589.8K | ★ 633.0K |
| Earning Date | 06-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $13,000,000.00 | ★ $271,103,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $50.03 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 85.71 | N/A |
| 52 Week Low | $9.20 | $2.30 |
| 52 Week High | $33.20 | $9.35 |
Technical Indicators
Market Signals| Indicator | EVMN | ASPN |
|---|---|---|
| Relative Strength Index (RSI) | 32.30 | 59.77 |
| Support Level | N/A | $5.34 |
| Resistance Level | $13.35 | $5.48 |
| Average True Range (ATR) | 0.66 | 0.20 |
| MACD | -0.18 | 0.07 |
| Stochastic Oscillator | 10.24 | 92.56 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.